Dark Horse Consulting Group (“DHC”), the longstanding global leader in strategic and operational consulting in the field of cell and gene therapy (“CGT”), is delighted to announce the acquisition of BioTechLogic, Inc. (“BioTechLogic”), a recognized forerunner in technical operations, manufacturing, quality, and regulatory CMC consulting. This strategic acquisition marks a significant milestone in DHC’s growth, combining the complementary strengths of both teams while further consolidating DHC’s position at the vanguard of CGT.
Read the full article: Dark Horse Consulting Group Acquires BioTechLogic, Inc. //
Source: https://www.globenewswire.com/news-release/2024/10/03/2957896/0/en/Dark-Horse-Consulting-Group-Acquires-BioTechLogic-Inc.html